Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

被引：1
|
作者：
Kaloyannidis, Panayotis [1 ]
Al Shaibani, Eshrak [1 ]
Apostolidis, Ioannis [1 ]
Kanfar, Solaf [1 ]
Al Anezi, Khalid [1 ]
Al Hashmi, Hani [1 ]
机构：
[1] King Fahad Specialist Hosp, Adults Hematol & Stem Cell Transplantat Dept, Dammam, Saudi Arabia
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷 / 05期
关键词：
STEM-CELL TRANSPLANTATION;
D O I：
10.1038/s41409-018-0362-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：746 / 748
页数：3
相关论文
共 50 条
  • [1] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Panayotis Kaloyannidis
    Eshrak Al Shaibani
    Ioannis Apostolidis
    Solaf Kanfar
    Khalid Al Anezi
    Hani Al Hashmi
    [J]. Bone Marrow Transplantation, 2019, 54 : 746 - 748
  • [2] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    [J]. TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [3] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [4] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Ferreira, Aliana Meneses
    Pontes da Silva, Carolina Atallah
    Pereira, Andre Domingues
    Szor, Roberta Shcolnik
    Brito Medeiros da Fonseca, Ana Rita
    Serpa, Mariana Gomes
    Xavier, Erick Menezes
    Sampaio de Melo, Michelly Kerly
    Novis, Yana
    Tucunduva, Luciana
    Rocha, Vanderson
    Arrais-Rodrigues, Celso
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 503 - 506
  • [5] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Aliana Meneses Ferreira
    Carolina Atallah Pontes da Silva
    André Domingues Pereira
    Roberta Shcolnik Szor
    Ana Rita Brito Medeiros da Fonseca
    Mariana Gomes Serpa
    Erick Menezes Xavier
    Michelly Kerly Sampaio de Melo
    Yana Novis
    Luciana Tucunduva
    Vanderson Rocha
    Celso Arrais-Rodrigues
    [J]. Bone Marrow Transplantation, 2018, 53 : 503 - 506
  • [6] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [7] Ruxolitinib for steroid-refractory graft-versus-host disease: A case series
    Lancman, Guido
    Coltoff, Alexander
    Steinberg, Amir
    [J]. HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 611 - 613
  • [8] Ruxolitinib in chronic steroid-refractory graft-versus-host-disease.
    Kovalenko, Iuliia
    Saleem, Tabinda
    Laek, Babray
    Ali, Rimsha
    Mirza, Taaha Muddassir
    Chattaraj, Asmi
    Wahab, Ahsan
    Din, Asma Tamez Ud
    Qurashi, Hafiz
    Golubykh, Konstantin
    Malik, Maidah
    Khan, Rafiullah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Diseas
    Toama, Wael
    Fiala, Mark A.
    Pusic, Iskra
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Wang, Dong
    Liu, Yin
    Lai, Xiaoxuan
    Chen, Jia
    Cheng, Qiao
    Ma, Xiao
    Lin, Zhihong
    Wu, Depei
    Xu, Yang
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
12345